The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Feb 18, 2025 | Stockwell Lynn | CEO and Exe. Chair of Board, Director, 10% Owner | Buy(P) | 30K | — | — |
| Feb 18, 2025 | Stockwell Lynn | CEO and Exe. Chair of Board, Director, 10% Owner | Buy(P) | 30K | — | — |
| Feb 18, 2025 | Drugs Made In America Acquisition LLC | 10% Owner | Buy(P) | 30K | — | — |
| Feb 18, 2025 | Drugs Made In America Acquisition LLC | 10% Owner | Buy(P) | 30K | — | — |
| Jan 29, 2025 | Worman Glenn C. | CFO | Other(J) | 100K | — | — |
| Jan 29, 2025 | Do Catherine | Director | Other(J) | 100K | — | — |
| Jan 29, 2025 | Prasad Sridhar G. | Director | Other(J) | 100K | — | — |
| Jan 29, 2025 | Shulgan Myron W. | Director | Other(J) | 100K | — | — |
| Jan 29, 2025 | Stockwell Lynn | CEO and Executive COB, Director, 10% Owner | Sell(S) | 5.7M | — | — |
| Jan 29, 2025 | Stockwell Lynn | CEO and Executive COB, Director, 10% Owner | Other(J) | 400K | — | — |
| Jan 29, 2025 | Stockwell Lynn | CEO and Executive COB, Director, 10% Owner | Buy(P) | 400K | — | — |
| Jan 29, 2025 | Stockwell Lynn | CEO and Executive COB, Director, 10% Owner | Buy(P) | 400K | — | — |
| Jan 29, 2025 | Drugs Made In America Acquisition LLC | 10% Owner | Buy(P) | 400K | — | — |
| Jan 29, 2025 | Drugs Made In America Acquisition LLC | 10% Owner | Sell(S) | 5.7M | — | — |
| Jan 29, 2025 | Drugs Made In America Acquisition LLC | 10% Owner | Other(J) | 400K | — | — |
| Jan 29, 2025 | Drugs Made In America Acquisition LLC | 10% Owner | Buy(P) | 400K | — | — |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).